Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Short-Term Debt issuances (2013 - 2014)

Updated

Sinovac Biotech (SVA) reported Short-Term Debt issuances of -$5.96 million for Q4 2014, compared with -$3.93 million a year earlier.

Analysis

Sinovac Biotech (SVA) Short-Term Debt issuances (2013 - 2014) Analysis & Trends

For FY2014, Sinovac Biotech posted Short-Term Debt issuances of -$15.96 million.

  • By year, Short-Term Debt issuances came in at -$4.09 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Sinovac Biotech 464.94 Mn -24.98 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -5.96 Mn
Dec 31, 2013 -3.93 Mn
API Access

Sinovac Biotech Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=SVA&period=max&api_key=YOUR_API_KEY